UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. )
ProUroCare Medical Inc.
(Name of Issuer)
Common Stock, par value $0.00001 per share
COMMON STOCK
(Title of Class of Securities)
74373C 10 7
(CUSIP Number)
February 13, 2012
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
/_/ Rule 13d-1(b)
/X/ Rule 13d-1(c)
/_/ Rule 13d-1(d)
|
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
74373C 10 7
CUSIP No.
--------------------------------------------------------------------------------
1) Names of Reporting Persons. Armen Sarvazyan
I.R.S. Identification Nos. of Above Persons (entities only)
--------------------------------------------------------------------------------
2) Check the Appropriate Box if a Member of a Group (a) [ ]
(See Instructions) (b) [ ]
--------------------------------------------------------------------------------
3) SEC Use Only
--------------------------------------------------------------------------------
4) Citizenship or Place of Organization United States
--------------------------------------------------------------------------------
Number of Shares 5) Sole Voting Power 867,878
Beneficially ---------------------------------------------------
Owned by Each 6) Shared Voting Power 140,386
Reporting ---------------------------------------------------
Person With 7) Sole Dispositive Power 867,878
---------------------------------------------------
8) Shared Dispositive Power 140,386
--------------------------------------------------------------------------------
9) Aggregate Amount Beneficially Owned by Each Reporting Person 998,264
--------------------------------------------------------------------------------
10) Check if the Aggregate Amount in Row (9) Excludes
Certain Shares (See Instructions) NA [ ]
--------------------------------------------------------------------------------
11) Percent of Class Represented by Amount in Item 9 6%
--------------------------------------------------------------------------------
12) Type of Reporting Person (See Instructions) IN
--------------------------------------------------------------------------------
|
ITEM 1.
(A) NAME OF ISSUER ProUroCare Medical Inc.
(B) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICE
6440 Flying Cloud drive, STE101, Eden Prairie, MN 55344
ITEM 2.
(A) NAME OF PERSONS FILING Armen Sarvazyan
(B) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR IF NONE, RESIDENCE
1753 Linvale-Harbourton Rd. Lambertville, NJ 08530
(C) CITIZENSHIP United States
(D) TITLE OF CLASS OF SECURITIES
Common Stock, par value $0.00001 per share
(E) CUSIP NUMBER 74373C 10 7
ITEM 3.
If this statement is filed pursuant to rule 240.13d- 1(b), or 240.13d-2(b)
or (c), check whether the person filing is a: NA
(a) ___ Broker or dealer registered under section 15 of the Act (15 U.S.C.
78o).
(b) ___ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) ___ Insurance company as defined in section 3(a)(19) of the Act (15
U.S.C. 78c).
(d) ___ Investment company registered under section 8 of the Investment
Company Act of 1940 (15 U.S.C. 80a-8).
(e) ___ An investment adviser in accordance with 240.13d- 1(b)(1)(ii)(E).
(f) ___ An employee benefit plan or endowment fund in accordance with
240.13d-1(b)(1)(ii)(F).
(g) ___ A parent holding company or control person in accordance with
240.13d-1(b)(1)(ii)(G)
(h) ___ A savings association as defined in section 3(b) of the Federal
Deposit Insurance Act (12 U.S.C. 1813).
(i) ___ A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the Investment Company
Act of 1940 (15 U.S.C. 80a-3).
(j) ___ Group, in accordance with section 240.13d-1(b)(1)(ii)(J).
ITEM 4. OWNERSHIP.
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned: 998,264
(b) Percent of class: 6%
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote: 867,878
(ii) Shared power to vote or to direct the vote: 140,386
(iii) Sole power to dispose or to direct the disposition of: 867,878
(iv) Shared power to dispose or to direct the disposition of: 140,386
Of the total securities reported, 122,386 represent common shares and 18,000
represent warrants currently exercisable that are owned by Artann Laboratories
Inc. of which Armen Sarvazyan is a minority shareholder and an officer.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS NA
If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following /___/.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
NA
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
NA
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
NA
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
NA
ITEM 10. CERTIFICATION.
By signing below we certify that, to the best of our knowledge and belief, the
securities referred to above were not acquired and are not held for the purpose
of or with the effect of changing or influencing the control of the issuer of
the securities and were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
Dated: February 13, 2012
By: /s/ Armen Sarvazyan
----------------------------
Name: Armen Sarvazyan
Title:
|
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From May 2024 to Jun 2024
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From Jun 2023 to Jun 2024
